Early Routine vs. Selective Human Milk Fortification in Extremely Preterm Infants
Completed · Not applicable
Conditions studied: Poor Growth in Extremely Preterm Infants, Necrotizing Enterocolitis
In brief
The aim of the project is to study the effects of fortification (using a Human Milk Donor Fortifier) of an exclusive preterm human milk diet on outcome of extremely preterm neonates, born at less or equal to 27 weeks.
Key facts
- Study ID
- NCT04284280
- Run by
- Crouse Hospital
- People needed
- 170
- Starts
- 2020-02-15
- Expected to finish
- 2025-11-11
- Last updated by the study team
- 2026-04-30
Who can join
Age: any, up to 0. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- All extremely preterm infants with gestational age less or equal to 27 weeks who are admitted to the NICU prior to day of life seven and the first enteral feeding
You may not qualify if…
- Infants with severe congenital anomalies such as chromosomal trisomy, congenital heart disease, and abdominal wall defect
Where it is running
- Crouse Hospital — Syracuse, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.